En | De
Sie sind hier: Onkologie » Urologische Tumoren 11. Juli 2020
Urologische Tumoren
Erweiterte Suche
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Endokrine Organe
Gynäkologische Tumoren
Urologische Tumoren
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 6446  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 128918  
A Sensitive Aptamer-Based Biosensor for Electrochemical Quantification of PSA as a Specific Diagnostic Marker of Prostate Cancer.
J Pharm Pharm Sci
Hassani S, Salek Maghsoudi A, Rezaei Akmal M, Rahmani SR, Sarihi P, Ganjali MR, Norouzi P, Abdollahi M.
PMID: 32649855 [PubMed - as supplied by publisher]

An ensemble approach of urine sediment image analysis and NMP22 test for detection of bladder cancer cells.
J Clin Lab Anal
Cho EJ, Kwon Bang C, Kim H, Kyung Lee H.
PMID: 32648637 [PubMed - as supplied by publisher]

Editorial Comment: Randomised Trial of Adjuvant Radiotherapy Following Radical Pros-tatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Posi-tive Margins or Extracapsular Extension.
Int Braz J Urol
Lott F.
PMID: 32648430 [PubMed - in process]

Editorial Comment: Cardiovascular Morbi-dity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Pati-ents with Advanced Prostate Cancer and Preexisting Cardiovascular Disease.
Int Braz J Urol
Lott F.
PMID: 32648429 [PubMed - in process]

Predicting Insignificant Prostate Cancer: Analysis of the Pathological Outcomes of Candidates for Active Surveillance according to the Pre-International Society of Urological Pathology (Pre-ISUP) 2014 Era Versus the Post-ISUP2014 Era.
World J Mens Health
Chung MS, Cho NH, Kim J, Jo Y, Yoon BI, Lee SH.
PMID: 32648380 [PubMed - as supplied by publisher]

Role of Multiparametric Magnetic Resonance Imaging in Predicting Pathologic Outcomes in Prostate Cancer.
World J Mens Health
Harland N, Stenzl A, Todenhöfer T.
PMID: 32648376 [PubMed - as supplied by publisher]

Oxidative Stress, Diet and Prostate Cancer.
World J Mens Health
Tan BL, Norhaizan ME.
PMID: 32648373 [PubMed - as supplied by publisher]

Physical activity and advanced cancer: evidence of exercise-sensitive genes regulating prostate cancer cell proliferation and apoptosis.
J Physiol
Schwappacher R, Schink K, Sologub S, Dieterich W, Reljic D, Friedrich O, Herrmann HJ, Neurath MF, Zopf Y.
PMID: 32648302 [PubMed - as supplied by publisher]

Prevention of Prostate Cancer in Transgenic Adenocarcinoma of the Mouse Prostate Mice by Yellow Passion Fruit Extract and Antiproliferative Effects of Its Bioactive Compound Piceatannol.
J Cancer Prev
Kido LA, Hahm ER, Kim SH, Baseggio AM, Cagnon VHA, Singh SV, Maróstica MR Jr.
PMID: 32647650 [PubMed]

A study on prostate movement and dosimetric variation because of bladder and rectum volumes changes during the course of image-guided radiotherapy in prostate cancer.
Prostate Int
Gurjar OP, Arya R, Goyal H.
PMID: 32647646 [PubMed]

A review of social determinants of prostate cancer risk, stage, and survival.
Prostate Int
Coughlin SS.
PMID: 32647640 [PubMed]

Experience of a tertiary referral center in managing bladder cancer in conjunction with neurogenic bladder.
Spinal Cord Ser Cases
Sampogna G, Maltagliati M, Galfano A, Bocciardi A, Rocco B, Micali S, Montanari E, Spinelli M.
PMID: 32647234 [PubMed - in process]

A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
BMC Med Inform Decis Mak
Zhang X, Zhang M, Zhang X, Zhu X, Wang J.
PMID: 32646427 [PubMed - in process]

MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?
Int J Mol Sci
Andl T, Ganapathy K, Bossan A, Chakrabarti R.
PMID: 32645914 [PubMed - in process]

Cancer, Renal

Pandey J, Syed W, Pandey J, Syed W.
PMID: 32644401 [PubMed]

Cancer, Sex Cord Stromal Testicular Tumor

Kapoor M, Budh DP, Kapoor M, Budh DP.
PMID: 32644342 [PubMed]

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
PLoS One
Sandeman K, Eineluoto JT, Pohjonen J, Erickson A, Kilpeläinen TP, Järvinen P, Santti H, Petas A, Matikainen M, Marjasuo S, Kenttämies A, Mirtti T, Rannikko A.
PMID: 32645056 [PubMed - in process]

Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts.
World J Urol
Elghazaly H, Mottet N, Garcia J, Oudard S, Roach M, Abbou C, Merseburger A, Emara A, Shehata S, Tawfik H, Khorshid O, Selim A, Assem A, Abdelkarim K, Ezz El-Arab L, Bazarbashi S, Omar A, Elwakil H, Elashry M, Abou ElFotouh M, Osman T, Ezz El Din M.
PMID: 32643031 [PubMed - as supplied by publisher]

Treatment of low-risk prostate cancer: a retrospective study with 477 patients comparing external beam radiotherapy and I-125 seeds brachytherapy in terms of biochemical control and late side effects.
Strahlenther Onkol
Moll M, Paschen C, Zaharie A, Berndl F, Goldner G.
PMID: 32642874 [PubMed - as supplied by publisher]

CD44v8-10 mRNA contained in serum exosomes as a diagnostic marker for docetaxel resistance in prostate cancer patients.
Kato T, Mizutani K, Kawakami K, Fujita Y, Ehara H, Ito M.
PMID: 32642575 [PubMed]

   Artikel 1 - 20 / 128918    Seite 1 von 6446  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer





Haben Sie Ihr Passwort vergessen?


Neu bei My Medline?

Melden Sie sich bei My Medline an!


Mehr über My Medline erfahren

mehr >>


Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.



mehr >>


Sky right 1